EntryPoint Capital’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$729K Sell
22,674
-506
-2% -$18K 0.21% 126
2025
Q4
$835K Buy
23,180
+14,767
+176% +$542K 0.33% 51
2025
Q3
$265K Sell
8,413
-2,146
-20% -$77.1K 0.1% 418
2025
Q2
$449K Buy
+10,559
New +$439K 0.23% 132
2024
Q3
Sell
-3,075
Closed -$141K 1165
2024
Q2
$141K Buy
3,075
+1,227
+66% +$57.9K 0.21% 147
2024
Q1
$96.1K Sell
1,848
-4,980
-73% -$218K 0.09% 451
2023
Q4
$243K Buy
+6,828
New +$238K 0.23% 52

Other funds holding VCEL

EntryPoint Capital's VCEL Position: Q1 2026 in Review

EntryPoint Capital reduced its Vericel Corp (VCEL) stake by 2.2% in Q1 2026, selling an estimated $18K and leaving 22,674 shares worth $729K. The position accounts for 0.21% of the portfolio, ranked #126.

EntryPoint Capital first reported a position in VCEL in Q4 2023 and has held it in 7 quarters since. The position peaked at $835K in Q4 2025. 279 funds tracked by Wall St. Rank hold VCEL as of Q1 2026.

  • EntryPoint Capital held 22,674 shares of Vericel Corp worth $729K as of Q1 2026.
  • EntryPoint Capital sold 506 Vericel Corp shares in Q1 2026, an estimated $18K.
  • Vericel Corp made up 0.21% of EntryPoint Capital's portfolio in Q1 2026, its #126 holding.
  • EntryPoint Capital first reported a position in Vericel Corp in Q4 2023 and has held it in 7 quarters since.
  • EntryPoint Capital's Vericel Corp position peaked at $835K in Q4 2025.
  • 279 funds tracked by Wall St. Rank held Vericel Corp as of Q1 2026.

Based on EntryPoint Capital's 13F filing for Q1 2026, filed 14 May 2026.